IMPORTANCE Staphylococcus aureus is a frequent cause of infection in hospitalized infants. These infections are associated with increased mortality and morbidity and longer hospital stays, but data on the burden of S aureus disease in hospitalized infants are limited.
length of hospital stay. 4 Staphylococcus aureus is the second most frequent cause of late-onset sepsis in very low-birthweight (VLBW) infants less than 1500 g 1 and is resistant to methicillin sodium in 8% to 28% of cases.
5-7
Antibiotic-resistant S aureus strains, specifically methicillin-resistant S aureus (MRSA), have emerged and become prevalent in neonatal intensive care units (NICUs). Because MRSA-colonized infants often serve as a reservoir for spread to other infants, many NICUs have developed procedures to detect and isolate colonized infants.
8, 9 Identification of colonization is often followed by efforts to eradicate MRSA. 8, 10 Although infection due to methicillin-susceptible S aureus (MSSA) also occurs, few centers have screening protocols for MSSA. 11 The proportion of nosocomial S aureus infections caused by MRSA has decreased in some settings, including NICUs. 12, 13 However, most studies 5,6,14 evaluating S aureus and MRSA in NICU patients have included small numbers of patients or culture sites and have been conducted in single institutions, at tertiary care centers, or within outbreak settings. Our objective was to describe the epidemiological characteristics of S aureus invasive infections using a large, nationally representative cohort of hospitalized infants.
Methods
We identified all infants with an invasive S aureus infection who were discharged from calendar year 1997 through calendar year 2012 from 348 NICUs managed by the Pediatrix Medical Group. This group cares for more than 20% of infants admitted to NICUs in the United States and is composed of academic and community sites in 34 states. Data were obtained from the electronic medical record generated prospectively by clinicians on all infants. Data were extracted, deidentified, and stored in the Pediatrix Clinical Data Warehouse. 13 Information on infants includes maternal history, birth information, and demographics. Medications, laboratory values, microbiology results, diagnoses, and procedures are recorded on a daily basis. Microbiology results are reported as documented by the treating physician in the medical record. This study was approved by the Duke University Institutional Review Board.
Definitions
Positive S aureus cultures obtained within 21 days of each other were considered to be a single infection. 15 Infections in which any positive culture was obtained from cerebrospinal fluid, blood, sterile fluid, or an abscess were considered to be invasive. Infections in which all positive cultures were obtained from the trachea, urine, conjunctiva, or a wound were considered to be noninvasive. Abscess cultures included all cultures labeled "abscess" and may have included both cutaneous and deep tissue abscesses. Because the method of collection was missing for most urine samples, positive urine cultures for MSSA and MRSA were considered to be noninvasive. Cultures obtained from the skin surface, umbilicus, rectum, nasopharynx, or gastric aspirate were considered to represent surveillance cultures. Noninvasive and surveillance cultures were excluded from the analysis. Cultures for which the specimen type was "unknown" or "other" were also excluded. Infections that had growth of both MSSA and MRSA were considered to be MRSA infections.
Inotropic support was defined as exposure to dopamine hydrochloride, dobutamine, epinephrine, norepinephrine bitartrate, or milrinone. Mechanical ventilation was defined as exposure to any invasive mechanical ventilation. Oxygen supplementation was defined as the administration of any fraction of inspired oxygen exceeding 21%. Antibiotic exposure was defined as exposure to any antibiotic. Anti-MRSA antibiotic exposure was defined as exposure to vancomycin, rifampin, linezolid, daptomycin, clindamycin, trimethoprimsulfamethoxazole, or mupirocin. Small-for-gestational-age status was defined as previously described. 16 
Statistical Analysis
We determined the proportion of S aureus infections that were methicillin resistant by year of discharge and by NICU site. We calculated the incidence of positive MSSA and MRSA infections per 10 000 admitted infants for each year.
Infant demographics were assigned to S aureus category (MRSA vs MSSA) by the type of the first invasive infection and were compared using Wilcoxon rank sum tests for continuous variables and χ 2 tests for categorical variables. Using Wilcoxon rank sum tests, we compared the median numbers of days of exposure to inotropic support, oxygen support, ventilator support, antibiotic use, and MRSA-active antibiotic use before the first positive invasive culture for infants with MRSA vs those parameters for infants with MSSA. We determined the number of deaths that occurred before hospital discharge and within 7 and 30 days after the first positive culture of an invasive infection, both overall and separately for infants born at less than 1500 g and for infants born at 1500 g or higher. For infants with more than 1 invasive infection, we considered the risk of death after the last infection. We compared the risk of death after an invasive MRSA infection with the risk of death after an invasive MSSA infection using modified Poisson regression adjusted for gestational age, small-for-gestational-age status, male sex, and race/ ethnicity, with random effects for site.
At a Glance
• Staphylococcus aureus is a frequent cause of infection in hospitalized infants. Table 1) . For all birth weight categories, MSSA was more common than MRSA.
Characteristics of Infants With MSSA and MRSA Disease
Most characteristics of infants with invasive MSSA and MRSA infections were similar, including gestational age, birth weight, and the proportions who were male, small for gestational age, or born by cesarean section ( Table 2) . For all races/ethnicities, MSSA was more common than MRSA. A higher proportion of infants with MRSA were African American than those with MSSA (330 of 1035 [31.9%] and 681 of 2725 [25.0%], respectively). The median postnatal age at occurrence was younger for MRSA infections (15 days [9-26 days for the 25th-75th percentiles]) than for MSSA infections (18 days [10-32 days for the 25th-75th percentiles]) (P < .001). When considering exposure to potential risk factors before the first invasive S aureus infection, the median duration of oxygen support before the infection was shorter in infants whose first invasive S aureus infection was MRSA (5 days [1-15 days for the 25th-75th percentiles]) than in infants whose first invasive S aureus infection was MSSA (8 days [1-20 days for the 25th-75th percentiles]) (P < .001). Previous exposure to a surgical procedure and the number of days of antibiotic use, MRSAactive antibiotic use, ventilator support, and inotropic support before the first invasive S aureus infection were similar for infants with MSSA and infants with MRSA.
Mortality of Infants With MSSA and MRSA Disease
Among the 2474 infants with invasive MSSA infections for whom mortality information was available, 237 (9.6%) died before hospital discharge. Mortality was similar among the 926 infants with invasive MRSA infections, with 110 (11.9%) dying before hospital discharge (P = .05).
Death before hospital discharge occurred more often in infants with invasive S aureus infection born at less than 1500 g (302 of 2596 [11.6%] ) vs born at 1500 g or higher (45 of 802 [5.6%]) (P < .01). When the risk of death was adjusted for gestational age group, small-for-gestational age status, sex, and race/ethnicity using random effects for site, there was no statistically significant difference in the risk of death after an invasive MSSA infection compared with after an invasive MRSA infection overall or separately for infants born at less than 1500 g vs born at 1500 g or higher ( Table 3 ). The risk of death was also similar at 7 and 30 days after the start day of the invasive infection. Copyright 2015 American Medical Association. All rights reserved.
Trends in Methicillin Resistance Over Time
cedures, and recent antibiotic therapy may predispose patients to infection with MRSA. In infants, some studies 6, 21, 22 have noted that low birth weight and younger gestational age, as well as a recent surgical procedure and prior treatment with systemic antibiotics, are associated with a higher incidence of MRSA colonization and subsequent infection. We found that infants who were of African American race/ethnicity, born at another hospital and transferred, and younger postnatal age had a greater proportion of S aureus infections that were MRSA than were MSSA. Other studies 6,23,24 have also noted that infants with MRSA infection have a younger postnatal age than infants with MSSA infection. This finding is intuitively unexpected because MRSA is often a hospital-associated infection, so we would expect that more days in the hospital and more days of antibiotic exposure would increase the risk of MRSA infections. Other studies 25-27 have found MRSA infections to be more common in African American patients as well. The reasons for this difference are not clear but may include variations in immune function, maternal colonization rates, or other unknown factors.
28
Worse outcomes after MRSA infections compared with after MSSA infections have been noted in older patients with bloodstream infections, 29,30 endocarditis, 31 and osteomyelitis. 32 However, differences in outcomes after MRSA infection vs after MSSA infection in infants have been less clear. We found no difference in adjusted mortality after MRSA compared with after MSSA invasive infection at 7 days, 30 days, or hospital discharge. A single-center study 6 of 172 S aureus infections in hospitalized infants found that mortality was similar between infants with MRSA and MSSA (16% vs 17%, respectively; P > .99), and length of hospital stay was also similar (64 days for MRSA and MSSA, P = .80). Another single-center study 24 found no differences in length of hospital stay (P = .70), death (P = .20), or the incidence of neurodevelopmental impairment at 12 to 36 months of age (P = .28) for 53 infants with MRSA bacteremia compared with that caused by MSSA. A multicenter retrospective study 5 of 316 infants found no difference in survival for infants born at 1500 g or less with MRSA vs MSSA bacteremia or meningitis. Given similar outcomes in infants with MRSA and MSSA disease, strategies should focus broadly on S aureus prevention and not solely on prevention of MRSA. Findings of singlecenter studies have suggested that MRSA screening and decolonization may reduce MRSA infection.
14 However, a lack of controlled clinical trials has led to a large variation in approaches in MRSA identification and treatment in the NICU. Although MSSA causes more infections and more deaths per year in infants, most centers only consider MRSA in their screening and decolonization protocols. 8 As previously described, a broader approach to S aureus prevention should go beyond MRSA to also include MSSA. 10 When MSSA has been included in screening and decolonization efforts, subsequent MSSA infections have decreased. 33, 34 One NICU was able to dramatically reduce both MRSA and MSSA infections with We opted to exclude surveillance and noninvasive cultures from the analysis because of differing surveillance practices (eg, centers with no surveillance, surveillance for MRSA only, and varying surveillance frequency and methods). Specimens from invasive infections may have been classified as surveillance cultures or noninvasive infections, but this number was likely small and should have been similar for MRSA and MSSA. Our analysis evaluated all-cause mortality and not S aureus-attributable mortality. However, the relative risk of death after invasive MRSA compared with after invasive MSSA is not likely to be influenced by this distinction.
Conclusions
The absolute numbers of infections and deaths due to MSSA exceed those due to MRSA. Consideration should be given to expanding hospital infection control efforts targeting MRSA to include MSSA as well. 10, 38, 39 Future studies to better define the relationship between MSSA colonization and subsequent infection will help to clarify the importance of such interventions for preventing MSSA disease.
